New Medicaid Bulletin Articles Available as of Sept. 26

The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles:

• Epcoritamab-bysp Injection, for Subcutaneous Use (Epkinly™) HCPCS Code J9999 - Not Otherwise Classified, Antineoplastic Drugs: Billing Guidelines - Effective with date of service June 2, 2023, NC Medicaid covers epcoritamab-bysp injection, for subcutaneous use (Epkinly)
• Food Insecurity and Housing Instability Screening Update - Additional clarification on implementation
• Policy Updates for Behavioral Health Providers - Clinical Coverage Policy 8A, Enhanced Mental Health and Substance Abuse Services and 8C, Outpatient Behavioral Health Services
• Risperidone Extended-release Injectable Suspension, for Subcutaneous Use (Uzedy™) HCPCS Code J3490 - Unclassified Drugs: Billing Guidelines - Effective with date of service May 26, 2023, NC Medicaid covers risperidone extended-release injectable suspension, for subcutaneous use (Uzedy)

Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.